0001209191-20-063314.txt : 20201214
0001209191-20-063314.hdr.sgml : 20201214
20201214184015
ACCESSION NUMBER: 0001209191-20-063314
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freund John Gordon
CENTRAL INDEX KEY: 0001296771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 201387654
MAIL ADDRESS:
STREET 1: 125 UNIVERSITY AVE.
STREET 2: C/O SKYLINE VENTURES
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-10
0
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001296771
Freund John Gordon
SKYLINE VENTURES
525 UNIVERSITY AVE., SUITE 1350
PALO ALTO
CA
94301
1
0
0
0
Common Stock
2020-12-10
4
J
0
118735
0.00
D
0
I
By Skyline Venture Management V, LLC
Common Stock
2020-12-10
4
J
0
56327
0.00
A
56327
I
By partnership
The shares reported on this form represent pro rata distributions, and not sales or purchases, of securities by the reporting entity to its partners.
These securities are held of record by Skyline Venture Management V, LLC ("Skyline Management"), of which the reporting person, a member of the issuer's board of directors, together with Yasunori Kaneko, are the managing directors, and each may be deemed to share voting and investment power over the securities held by Skyline Management. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
These securities are held of record by the John Freund Family Partnership IV, L.P.
/s/ Edward C. Albini as attorney-in-fact for John G. Freund
2020-12-14